Small Ruminant Therapeutic Center to Speed Safe Drugs for Sheep and Goats
Official title: Small Ruminant Pharmacology and Drug Evaluation Center: Building Scalable Infrastructure for Minor Species Therapeutic Approval
Funded at North Carolina State University Raleigh · NIH-11567015 · Data updated 2026-11-12
A pilot project at a university will help scientists and veterinarians speed up and improve how drugs are tested and approved for sheep and goats.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $532,091 |
| NIH project number | 1U18FD008953-01 |
| Project ID | NIH-11567015 on NIH RePORTER |
Who could benefit from this research
✓Could help
Veterinarians, producers, and researchers working with sheep and goats who may participate in or benefit from future studies within the center’s framework.
✕Less likely to help
Direct patient benefits may be limited to those involved in early-stage trials or data generation; broader impacts depend on future approvals.
What this research studies
This project is building a collaborative Center that combines administration, pharmacology, antimicrobial stewardship, and data sharing to generate the evidence needed for safer and more effective medicines for small ruminants. The pilot will study florfenicol to create pharmacology, residue, resistance, and clinical outcome data that support future approvals. By establishing standardized processes and datasets, veterinarians and producers could have clearer guidance and faster access to approved therapies for sheep and goats.
Why it matters
Potential benefit: If successful, this work could lead to more approved treatments and better antimicrobial stewardship for small ruminants, reducing residue risks and improving animal health.
How similar studies have gone: Past efforts show that dedicated pharmacology and data integration can support new drug approvals in minor species, though this specific center is a new, integrated framework.
Where this research is happening
-
North Carolina State University Raleigh
Raleigh, United States Active
Researchers
- Principal investigator: Halleran, Jennifer — North Carolina State University Raleigh
- Study coordinator: Halleran, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.